MedTrace Logo

Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent

NCT00492908 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2014-05-01

No results posted yet for this study

Summary

A Randomized Comparison of a Titanium-Nitride-Oxide Coated Stent (Helistent Titan2, Hexacath) With a Zotarolimus-Eluting Stent (EndeavorTm, Medtronic) for Percutaneous Coronary Intervention

Conditions

Interventions

DEVICE

Helistent Titan2 (Titanium coated stent)

Titan2

DEVICE

EndeavorTM (Zotarolimus-Eluting Stent)

Endeavor

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • University of Bern

    lead OTHER

Principal Investigators

  • Stephan Windecker, MD · Department of Cardiology, University Hospital Bern, Bern, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-03-31
Completion
2013-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00492908 on ClinicalTrials.gov